Julia Lai‐Kwon

829 total citations
47 papers, 418 citations indexed

About

Julia Lai‐Kwon is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Julia Lai‐Kwon has authored 47 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 17 papers in Public Health, Environmental and Occupational Health and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Julia Lai‐Kwon's work include Cancer survivorship and care (16 papers), Palliative Care and End-of-Life Issues (11 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Julia Lai‐Kwon is often cited by papers focused on Cancer survivorship and care (16 papers), Palliative Care and End-of-Life Issues (11 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Julia Lai‐Kwon collaborates with scholars based in Australia, United States and United Kingdom. Julia Lai‐Kwon's co-authors include Michael Jefford, Anna Minchom, Claudia Rutherford, Karolina Lisy, Shahneen Sandhu, Tracey Weiland, Christina Yap, George A Jelinek, Alvin H Chong and Donna Milne and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Social Science & Medicine.

In The Last Decade

Julia Lai‐Kwon

44 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Lai‐Kwon Australia 12 275 98 78 68 53 47 418
Catherine Bender United States 10 162 0.6× 102 1.0× 45 0.6× 104 1.5× 48 0.9× 16 462
Helen Kerr United Kingdom 9 280 1.0× 74 0.8× 78 1.0× 62 0.9× 56 1.1× 21 532
Elham Hedayati Sweden 12 165 0.6× 79 0.8× 111 1.4× 30 0.4× 49 0.9× 44 438
Noha Sharafeldin United States 11 159 0.6× 65 0.7× 85 1.1× 33 0.5× 37 0.7× 29 497
Nakul Singh United States 15 124 0.5× 40 0.4× 41 0.5× 51 0.8× 76 1.4× 40 532
Viswatej Avutu United States 7 250 0.9× 40 0.4× 74 0.9× 69 1.0× 18 0.3× 21 331
Daniel S. O’Neil United States 13 230 0.8× 68 0.7× 35 0.4× 21 0.3× 22 0.4× 38 401
C. Louzado Canada 7 250 0.9× 96 1.0× 90 1.2× 68 1.0× 31 0.6× 11 442
Dori Klemanski United States 13 503 1.8× 143 1.5× 123 1.6× 102 1.5× 144 2.7× 23 807
Reza Bahrami Iran 11 109 0.4× 170 1.7× 86 1.1× 152 2.2× 37 0.7× 73 675

Countries citing papers authored by Julia Lai‐Kwon

Since Specialization
Citations

This map shows the geographic impact of Julia Lai‐Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Lai‐Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Lai‐Kwon more than expected).

Fields of papers citing papers by Julia Lai‐Kwon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Lai‐Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Lai‐Kwon. The network helps show where Julia Lai‐Kwon may publish in the future.

Co-authorship network of co-authors of Julia Lai‐Kwon

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Lai‐Kwon. A scholar is included among the top collaborators of Julia Lai‐Kwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Lai‐Kwon. Julia Lai‐Kwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lai‐Kwon, Julia, Michael Jefford, Stephanie Best, et al.. (2025). Mapping immune checkpoint inhibitor side effects to item libraries for use in real-time side effect monitoring systems. Journal of Patient-Reported Outcomes. 9(1). 27–27. 1 indexed citations
2.
3.
Lai‐Kwon, Julia, Nicolas H. Hart, Raymond J. Chan, et al.. (2024). Delivering improved survivorship care for people affected by advanced or metastatic cancer. Acta Oncologica. 63. 939–942. 1 indexed citations
4.
Lai‐Kwon, Julia, Renaud Tissier, Anke Kuijpers, et al.. (2024). Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy. European Journal of Cancer. 200. 113601–113601. 4 indexed citations
5.
6.
Lai‐Kwon, Julia, et al.. (2024). Selecting Immune Checkpoint Inhibitor Side Effects for Real-Time Monitoring in Routine Cancer Care: A Modified Delphi Study. JCO Oncology Practice. 20(12). 1663–1675. 2 indexed citations
7.
Lai‐Kwon, Julia, Elissa Thorner, Claudia Rutherford, Norah L. Crossnohere, & Michael Brundage. (2024). Integrating Patient-Reported Outcomes Into the Care of People With Advanced Cancer—A Practical Guide. American Society of Clinical Oncology Educational Book. 44(3). e438512–e438512. 5 indexed citations
8.
Lopez, Juanita, Julia Lai‐Kwon, R. Molife, et al.. (2023). A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma. British Journal of Cancer. 129(5). 811–818. 10 indexed citations
9.
Cheng, Phil F., et al.. (2023). Health‐related quality of life in survivors of advanced melanoma treated with anti‐PD1‐based immune checkpoint inhibitors. Cancer Medicine. 12(11). 12861–12873. 5 indexed citations
10.
Leeuwen, Marieke van, Annelies H. Boekhout, Julia Lai‐Kwon, et al.. (2023). Common toxicities associated with immune checkpoint inhibitors and targeted therapy in the treatment of melanoma: A systematic scoping review. Critical Reviews in Oncology/Hematology. 183. 103919–103919. 4 indexed citations
11.
Lai‐Kwon, Julia, Matteo S. Carlino, Naima Benannoune, et al.. (2023). Efficacy of ipilimumab 3 mg/kg following progression on low-dose ipilimumab in metastatic melanoma. European Journal of Cancer. 186. 12–21. 1 indexed citations
12.
Lai‐Kwon, Julia, Sathana Dushyanthen, Femke Buisman‐Pijlman, et al.. (2023). Designing a wholly online, multidisciplinary Master of Cancer Sciences degree. BMC Medical Education. 23(1). 544–544. 1 indexed citations
13.
14.
Lai‐Kwon, Julia, Anna Minchom, Olalekan Lee Aiyegbusi, et al.. (2022). Using Patient-Reported Outcomes in Dose-Finding Oncology Trials: Surveys of Key Stakeholders and the National Cancer Research Institute Consumer Forum. The Oncologist. 27(9). 768–777. 6 indexed citations
15.
Lai‐Kwon, Julia, et al.. (2022). Feasibility, acceptability, and utility of a nurse-led survivorship program for people with metastatic melanoma (MELCARE). Supportive Care in Cancer. 30(11). 9587–9596. 11 indexed citations
16.
Flore, Jacinthe, et al.. (2022). Entanglements and imagined futures: The subject(s) of precision in oncology. Social Science & Medicine. 317. 115608–115608. 1 indexed citations
17.
Lisy, Karolina, Julia Lai‐Kwon, Andrew C. Ward, et al.. (2020). Patient-reported outcomes in melanoma survivors at 1, 3 and 5 years post-diagnosis: a population-based cross-sectional study. Quality of Life Research. 29(8). 2021–2027. 11 indexed citations
18.
Lai‐Kwon, Julia, et al.. (2020). 585P Trends in patient-reported outcome (PRO) use in early phase oncology trials. Annals of Oncology. 31. S495–S495. 3 indexed citations
19.
Scott, David A., Lisbeth Evered, Richard Gerraty, et al.. (2014). Cognitive dysfunction follows left heart catheterisation but is not related to microembolic count. International Journal of Cardiology. 175(1). 67–71. 7 indexed citations
20.
Lai‐Kwon, Julia, et al.. (2013). A three year retrospective study on dermatological conditions presenting to a tertiary Emergency Department in Australia: Preliminary data. Australasian Journal of Dermatology. 54. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Bender Breakdown of academic impact, for papers by Helen Kerr Breakdown of academic impact, for papers by Elham Hedayati Breakdown of academic impact, for papers by Noha Sharafeldin Breakdown of academic impact, for papers by Nakul Singh Breakdown of academic impact, for papers by Viswatej Avutu Breakdown of academic impact, for papers by Daniel S. O’Neil Breakdown of academic impact, for papers by C. Louzado Breakdown of academic impact, for papers by Dori Klemanski Breakdown of academic impact, for papers by Reza Bahrami
Rankless by CCL
2026